| Message | Subject | Recs | Date/Time (ET) |
| Anti PD-1 mAbs were in the spotlight at AAI earlier this month. Sort of a tell : | Biotech Valuation | | 05/13/2013 03:33:52 AM |
| [color=rgb(31, 73, 125)]Robert Langer is, to my mind, of the most imaginative sc | Biotech Valuation | 1 | 05/06/2013 10:03:15 AM |
| The PCSK9 story
Genetics: A gene of rare effect
A mutation that gives pe | Biotech News | | 04/12/2013 08:25:43 AM |
| [color=rgb(40, 40, 40)]An interesting way of viewing cancer[/color]
[color=rgb( | Indications -- Cancer | 3 | 04/05/2013 10:11:56 AM |
| UTHR moves to phase I
http://maya.tase.co.il/bursa/report.asp?report_cd=798 | Pluristem Life Systems, Inc. | 1 | 02/26/2013 03:35:03 PM |
|
Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplasti | Pluristem Life Systems, Inc. | 2 | 02/21/2013 04:22:29 AM |
|
I thought that lacking the Fc region (which is also part of being small) resu | Biotech Valuation | | 02/16/2013 10:33:49 AM |
| PLX 19% on buyout rumors. | biotech fireworks | | 02/05/2013 09:59:02 AM |
| A recent review on the topic:
Hiding in plain view: the potential for commonl | Indications -- Cancer | | 01/07/2013 03:25:48 AM |
| This is the 2nd recent big push for the neuroinflammation hypothesis of AD, the | Biotech Valuation | | 11/30/2012 07:40:32 AM |
| Preclinical basic research
Dedifferentiation of Neurons and Astrocytes by On | Indications -- Cancer | | 11/18/2012 01:52:32 PM |
| This comment by Professor Leigh Turner of the University of Minnesota Center for | Pluristem Life Systems, Inc. | | 11/12/2012 08:57:32 AM |
| "A seven year-old girl who received a compassionate treatment died"
The sto | Pluristem Life Systems, Inc. | | 11/08/2012 10:15:26 AM |
| The trigger for my post was a call from frightened friend who wanted to know wha | Biotech Valuation | | 11/07/2012 11:32:04 AM |
| Peter,
23andme can determine APOE variant status unambiguously from two SNPs. | Biotech Valuation | | 11/07/2012 08:25:19 AM |
| BMRN up 29% on success for phase III GALNS trial in Morquio
| biotech fireworks | | 11/05/2012 10:47:39 AM |
| Probably scripts data like this guy noted "[color=rgb(51, 51, 51)]Two drug-trac | biotech firesales | | 10/31/2012 01:14:46 PM |
| >> I pray for the peace of Jerusalem<<
Can you please add Tel-Aviv to your | Biotech Valuation | 5 | 09/19/2012 09:17:59 AM |
| Cell Therapy Improves Hearing in Deaf Rodents
[url=http://www.genengnews.com/ | Biotech News | | 09/14/2012 10:55:59 AM |
| A third similar case:
[url=http://maya.tase.co.il/bursa/report.asp?report_cd= | Pluristem Life Systems, Inc. | | 09/05/2012 05:56:56 AM |
| A [color=rgb(34, 34, 34)] compilation of street thoughts and possible outcomes | Biotech Valuation | | 06/28/2012 09:48:14 AM |
|
20% job cuts
[url=http://finance.yahoo.com/news/complete-genomics-cuts-job | Complete Genomics GNOM DNA analysis for | | 06/05/2012 10:02:59 AM |
| First approved patent for 23andMe on [color=rgb(34, 34, 34)]susceptibility to P | Personalized Medicine: Molecular Dx | | 05/31/2012 02:02:54 PM |
|
Not All 'Good Cholesterol' Is 'Good': Raising HDL Not a Sure Route to Counte | Indications -- cardiovascular | | 05/17/2012 11:21:51 AM |
| Two notes on competitors:
Ariosa Diagnostics Announces Nationwide Launch of t | Sequenom, Inc. (SQNM) | | 05/08/2012 11:45:05 AM |
| Not only the malignancy risk also sounds like the FDA is not impressed by effica | Regeneron Pharmaceuticals | | 05/04/2012 03:17:23 PM |
| Basic research
http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/ar | Biotech News | | 04/30/2012 01:21:18 PM |
| Breast cancer rules rewritten in 'landmark' study
[url=http://www.bbc.co.uk/n | Indications -- Cancer | | 04/19/2012 02:59:48 PM |
| Sequenom, Inc. Pre-Announces First Quarter 2012 Total Test Volumes Including Mat | Sequenom, Inc. (SQNM) | | 04/16/2012 02:16:00 PM |
| Happy Passover and easy digestion to all the [i]matzo eaters :-)[/i] | Biotech Valuation | 1 | 04/06/2012 05:40:35 AM |
|
Personalized Cancer Care in an Age of Anxiety
[url=http://onlinelibrary.wil | Personalized Medicine: Molecular Dx | | 04/05/2012 04:07:30 PM |
| Keep exercising, Roy :-) | Biotech Valuation | | 04/05/2012 02:06:55 PM |
| Ouch on your injuries. As years go by, I shifted the core of my physical activi | Biotech Valuation | 1 | 04/05/2012 08:28:43 AM |
| Cool presentation:
[url=http://www.youtube.com/watch?v=aUaInS6HIGo&feature= | Biotech Valuation | 4 | 04/04/2012 05:44:44 PM |
| I'd think the trend in OS was also not enough. | ARIAD Pharmaceuticals | | 03/20/2012 03:59:54 PM |
| SQNM closed +16% on MaterniT21 test volumes:
[url=http://finance.yahoo.com/ne | biotech fireworks | | 03/09/2012 01:52:14 AM |
| You're doing a great job with my spelling errors, I just wish you could have don | Complete Genomics GNOM DNA analysis for | | 02/14/2012 02:33:16 PM |
| Financial terms of the deal with Mayo were not disclosed but obviously the marke | Complete Genomics GNOM DNA analysis for | | 02/14/2012 09:17:44 AM |
| Hi Jim and thanks for mentioning the Gordon group work. Since I believe we both | Biotech Valuation | | 02/14/2012 02:32:23 AM |
| More on the subject of how gut bacteria influence the biochemistry and developm | Biotech Valuation | | 02/13/2012 03:36:07 AM |
| Yes, they are indeed in trouble as these 800-pound gorillas are ahead of them wi | Complete Genomics GNOM DNA analysis for | | 01/31/2012 07:54:33 AM |
| I don't think so. Complete Genomics has its own NGS technology and provides seq | Complete Genomics GNOM DNA analysis for | 1 | 01/30/2012 07:52:27 AM |
| [color=rgb(51, 51, 51)]Life Technologies has unveiled their Ion Proton sequencer | Complete Genomics GNOM DNA analysis for | | 01/30/2012 03:40:16 AM |
| 6 more months and that retracted Sebastiani et. al. paper was reanalyzed with h | Biotech Valuation | | 01/22/2012 01:16:19 AM |
| LIFE won the "whole genome sequencing for $1000" race:
Life Technologies In | Genomics... | | 01/10/2012 05:27:20 AM |
|
Basic research
Potential new use for Zetia: blocks HCV entry in vitro
[ | Indications -- Hepatitis | | 01/09/2012 11:29:11 AM |
| Basic research
Inhibition or loss of PKR results in robust and consistent e | Biotech News | | 12/20/2011 01:45:00 PM |
|
[b]A coauthor of the key paper that led to one of this year’s Nobel Prizes for | Biotech Valuation | | 12/19/2011 12:44:09 PM |
| >It's standard practice to give EPO at the same time as dialysis - that's the wa | Biotech Valuation | | 12/10/2011 02:51:02 PM |
| Thanks, but that doesn't answer my question on the less frequent dosing, which I | Biotech Valuation | | 12/09/2011 06:40:00 AM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
